Search

    Language Settings
    Select Website Language

    GDPR Compliance

    We use cookies to ensure you get the best experience on our website. By continuing to use our site, you accept our use of cookies, Privacy Policy, and Terms of Service.

    BijnorNews
    Bijnor news

    US FDA Rejects Summit's China-Originated Lung Cancer Drug

    1 day ago

    The FDA issued a so-called Complete Response Letter saying that it can't approve Summit's application in its present form because the drug didn't help patients live longer in a statistically significant way.
    Click here to Read More
    Previous Article
    Private Hospitals Corner Rs 2.67 Lakh Crore, Nearly Double Government Hospital Spend in FY24
    Next Article
    Trade Setup For Nov 16: Nifty Likely To Resume Rally Despite Friday's Sell-Off; Key Levels To Watch

    Related Business Updates:

    Are you sure? You want to delete this comment..! Remove Cancel

    Comments (0)

      Leave a comment